Fig. 1 · Structure
Documents & Downloads
Etarotene
Antitumor Agent
Etarotene is an orally active antitumor agent that acts as a retinoid derivative. It demonstrates significant efficacy against DMBA-induced mammary tumors in preclinical models. Additionally, Etarotene has been associated with toxic symptoms resembling hypervitaminosis A in rat studies, highlighting its potent biological activity and potential implications in cancer research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 87719-32-2 |
| Applications | Antitumor Agent |
| Formula | C25H32O2S |
| Molecular Weight | 396.59 |
| Synonyms | Ro 15-1570 |
| SMILES | CC1(C)CCC(C)(C)C2=C1C=C(/C(C)=C/C3=CC=C(S(=O)(CC)=O)C=C3)C=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.